Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
3(60.0%)
N/A
1(20.0%)
Early Phase 1
1(20.0%)
5Total
Phase 2(3)
N/A(1)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05595538Early Phase 1Completed

Use of Multiple Doses of Convalescent Plasma in Mechanically Intubated Patients With COVID-19

Role: collaborator

NCT03360240Completed

Blood Pressure in Adolescents With PReclampsia and Eclampsia.

Role: lead

NCT02317146Phase 2Completed

Magnesium Sulfate in Pregnancy and Postpartum

Role: lead

NCT02307201Phase 2Completed

Magnesium Sulfate During the Postpartum in Women With Severe Preeclampsia

Role: lead

NCT01988298Phase 2Completed

Nonsteroidal Antiinflammatory Drugs in Women With Postpartum Pre-eclampsia

Role: lead

NCT01164852Not ApplicableCompleted

Aggressive Versus Expectant Management of Severe Preeclampsia Remote From Term

Role: lead

All 6 trials loaded